Fabian Szepanowski
Overview
Explore the profile of Fabian Szepanowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mausberg A, Szepanowski F, Eggert B, Liebig K, Kleinschnitz C, Kieseier B, et al.
Immunol Res
. 2024 Dec;
73(1):12.
PMID: 39674966
The inhibition of the neonatal Fc receptor (FcRn) is a promising therapeutic pathway in certain autoimmune disorders to reduce the amount of circulating pathogenic IgG autoantibodies by interfering with their...
2.
Szepanowski F, Zipfel J, Szepanowski R, Eggert B, Guner N, Szepanowski L, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334697
Nuclear erythroid 2-related factor 2 (Nrf2) and its downstream effector heme oxygenase 1 (HO-1) are commonly activated in response to cellular stresses. The elevated expression of HO-1 has been associated...
3.
Quint P, Schroeter C, Kohle F, Ozturk M, Meisel A, Tamburrino G, et al.
J Neurol
. 2024 Jul;
271(9):5930-5943.
PMID: 38990346
Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) is an inflammatory disease affecting the peripheral nerves and the most frequent autoimmune polyneuropathy. Given the lack of established biomarkers or risk factors for...
4.
Fleischer M, Szepanowski F, Mausberg A, Asan L, Uslar E, Zwanziger D, et al.
Ther Adv Neurol Disord
. 2024 Jun;
17:17562864241255819.
PMID: 38827242
No abstract available.
5.
Fleischer M, Szepanowski F, Mausberg A, Asan L, Uslar E, Zwanziger D, et al.
Ther Adv Neurol Disord
. 2024 Feb;
17:17562864241229567.
PMID: 38348267
Background: Post-acute sequelae of COVID-19 (PASC) comprise a broad spectrum of symptoms such as fatigue, general weakness, compromised attention and sleep or anxiety disorders. PASC represents a medical and socio-economic...
6.
Szepanowski F, Schoser B, Mausberg A, Kleinschnitz C, Hartung H, Stettner M
Brain Behav
. 2023 Sep;
13(11):e3256.
PMID: 37743581
Standardized pharmacological response tests are important and established diagnostic tools in the field of neurology. However, regarding therapeutic responses to intravenous immunoglobulins (IVIg) in CIDP, neither a definition of therapeutic...
7.
Szepanowski F, Stettner M
Neural Regen Res
. 2023 Jul;
18(12):2651-2652.
PMID: 37449606
No abstract available.
8.
Szepanowski F, Steubing R, Gungor C, Zipfel J, Mausberg A, Kleinschnitz C, et al.
Neural Regen Res
. 2022 Dec;
18(7):1623-1624.
PMID: 36571371
No abstract available.
9.
Fleischer M, Szepanowski F, Tovar M, Herchert K, Dinse H, Schweda A, et al.
Neurol Ther
. 2022 Aug;
11(4):1637-1657.
PMID: 36028604
Introduction: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect multiple organs. Reports of persistent or newly emergent symptoms, including those related to the nervous system, have increased over...
10.
Steubing R, Szepanowski F, David C, Mohamud Yusuf A, Mencl S, Mausberg A, et al.
Brain Behav Immun Health
. 2022 Aug;
24:100493.
PMID: 35928516
Platelets are key mediators of thrombus formation and inflammation during the acute phase of ischaemic stroke. Particularly, the platelet glycoprotein (GP) receptors GPIbα and GPVI have been shown to mediate...